why choose us

First received: July 17, 2023

Clinical Trial: A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-Dose Study to Assess the Relative Bioavailability and Tolerability of Subcutaneous Peresolimab Test Formulations in Healthy Participants

Brief Summary: The main purpose of this study is to look at the amount of the study drug, peresolimab, that gets into the blood stream and how long it takes the body to get rid of it when given under the skin using test formulations versus reference formulation in healthy participants.The study will also evaluate the safety and tolerability of peresolimab and information about any side effects experienced will be collected.For each participant, the total duration of the study will be approximately up to 17 weeks, including…

Read more